Business Club December 20th The European Commission recently confirmed that its anti-monopoly law enforcement officers have started surprise searches of several pharmaceutical companies in the European Union because they are suspected of impeding the listing of certain generic drugs and violate EU antitrust regulations.
According to relevant sources from the European Commission, there is reason to believe that these companies may individually or conspire to engage in violations of EU antitrust regulations, in particular to prevent the listing of certain generic drugs. According to the usual practice, the European Commission did not announce the name of the company involved and other details.
The raid search is a preparatory phase of anti-monopoly procedures in the EU and it is intended to collect evidence to determine whether to launch an antitrust investigation.
In recent years, the European Commission has initiated special anti-monopoly governance for the pharmaceutical industry. The European Commission believes that there are indications that the competition in the EU pharmaceutical market is not sufficient. Some pharmaceutical companies try to prevent cheap generic drugs from entering the market for profiteering, which puts the patient’s economic burdens even further.
In November 2008, the European Commission conducted raids on several pharmaceutical companies in several EU member states.
It is estimated that Europeans spend about 400 euros per person per year on medicine, and the market size amounts to about 200 billion euros.
According to relevant sources from the European Commission, there is reason to believe that these companies may individually or conspire to engage in violations of EU antitrust regulations, in particular to prevent the listing of certain generic drugs. According to the usual practice, the European Commission did not announce the name of the company involved and other details.
The raid search is a preparatory phase of anti-monopoly procedures in the EU and it is intended to collect evidence to determine whether to launch an antitrust investigation.
In recent years, the European Commission has initiated special anti-monopoly governance for the pharmaceutical industry. The European Commission believes that there are indications that the competition in the EU pharmaceutical market is not sufficient. Some pharmaceutical companies try to prevent cheap generic drugs from entering the market for profiteering, which puts the patient’s economic burdens even further.
In November 2008, the European Commission conducted raids on several pharmaceutical companies in several EU member states.
It is estimated that Europeans spend about 400 euros per person per year on medicine, and the market size amounts to about 200 billion euros.
The fresh and natural taste is always attractive to people. When you are confused, drowsy and need to relax, if you take a few minutes to feel the aroma of the fruit, the situation will be completely different. As you know, blueberry flavor has always been popular with people. Therefore, we have developed and produced blueberry-flavored cigarette substitutes to help people feel the comfort of nature anytime, anywhere.
Green Smoke Cartridges,Blueberry Flavor E-Cigarette,Blueberry Plant Extracts Cigarette,Blueberry E-Cigarette Alternative
Dongguan Vanilla Bioengineering Co., Ltd. , https://www.healthecigarette.de